Gandhinagar, Sept. 1 -- Gujarat is contributing to India's pharmaceutical sector's growth, anchored by supportive government initiatives and investment opportunities. It is home to global companies such as Sun Pharma, Zydus Cadila, Intas Pharmaceuticals, Amneal Pharmaceuticals, and many more.
The North Gujarat region contributes 12% in the state's manufacturing output of pharmaceuticals. Mehsana presents significant opportunities in the manufacturing of bulk drugs, APIs, intermediates, and formulations, supported by established companies like Torrent Pharma. Its USFDA-approved plant, located at Indrad (Kadi, Mehsana), manufactures both API and formulations with an annual capacity of 30 million vials. The Plant also hosts a dedicated faci...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.